S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.neuint.2022.105442 http://hdl.handle.net/11449/246387 |
Resumo: | S-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation. |
id |
UNSP_01031290c9ccae1573250195563588f3 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/246387 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors5-HT5-HT1ADepressionS-adenosyl-l-methionineSAMeSerotoninStressS-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Pharmacology School of Medicine of Ribeirão Preto University of São Paulo (USP), Ribeirão Preto-SPLaboratory of Pharmacology School of Pharmaceutical Sciences of Araraquara São Paulo State University (UNESP), Araraquara-SPCenter for Interdisciplinary Research on Applied Neurosciences (NAPNA) University of São Paulo (USP)Department of Biomolecular Sciences School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo (USP), Ribeirão Preto-SPDepartment of Biomedicine Aarhus UniversityLaboratory of Pharmacology School of Pharmaceutical Sciences of Araraquara São Paulo State University (UNESP), Araraquara-SPFAPESP: 2015/01955–9 2018/15896–3Universidade de São Paulo (USP)Universidade Estadual Paulista (UNESP)Aarhus UniversitySales, Amanda J.Maciel, Izaque S.Crestani, Carlos C. [UNESP]Guimarães, Francisco S.Joca, Sâmia RL.2023-07-29T12:39:31Z2023-07-29T12:39:31Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.neuint.2022.105442Neurochemistry International, v. 162.1872-97540197-0186http://hdl.handle.net/11449/24638710.1016/j.neuint.2022.1054422-s2.0-85142770155Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengNeurochemistry Internationalinfo:eu-repo/semantics/openAccess2023-07-29T12:39:31Zoai:repositorio.unesp.br:11449/246387Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:23:37.998672Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
title |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
spellingShingle |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors Sales, Amanda J. 5-HT 5-HT1A Depression S-adenosyl-l-methionine SAMe Serotonin Stress |
title_short |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
title_full |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
title_fullStr |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
title_full_unstemmed |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
title_sort |
S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors |
author |
Sales, Amanda J. |
author_facet |
Sales, Amanda J. Maciel, Izaque S. Crestani, Carlos C. [UNESP] Guimarães, Francisco S. Joca, Sâmia RL. |
author_role |
author |
author2 |
Maciel, Izaque S. Crestani, Carlos C. [UNESP] Guimarães, Francisco S. Joca, Sâmia RL. |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Estadual Paulista (UNESP) Aarhus University |
dc.contributor.author.fl_str_mv |
Sales, Amanda J. Maciel, Izaque S. Crestani, Carlos C. [UNESP] Guimarães, Francisco S. Joca, Sâmia RL. |
dc.subject.por.fl_str_mv |
5-HT 5-HT1A Depression S-adenosyl-l-methionine SAMe Serotonin Stress |
topic |
5-HT 5-HT1A Depression S-adenosyl-l-methionine SAMe Serotonin Stress |
description |
S-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-29T12:39:31Z 2023-07-29T12:39:31Z 2023-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.neuint.2022.105442 Neurochemistry International, v. 162. 1872-9754 0197-0186 http://hdl.handle.net/11449/246387 10.1016/j.neuint.2022.105442 2-s2.0-85142770155 |
url |
http://dx.doi.org/10.1016/j.neuint.2022.105442 http://hdl.handle.net/11449/246387 |
identifier_str_mv |
Neurochemistry International, v. 162. 1872-9754 0197-0186 10.1016/j.neuint.2022.105442 2-s2.0-85142770155 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Neurochemistry International |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128926326718464 |